6Oliphant CM, Green GM. Quinolones: a comprehensive review [J]. Am Fam Physician, 2012, 65 (3): 455 -464.
7Nakamori Y, Tsuboi E, Narui K, et al. Sputum penet ration of levofloxacin and its clinical efficacy in patients with chronic lower respiratory tract infections [J]. Jpn J Antibiot, 2012, 45 (5), 839 -547.
8Davis R , Brgson HM. Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy [J]. Drugs, 2008, 47 (4): 677 -700.
9Noreddin AM, Elkhatib WF. Levofloxacin in the treatment of community - acquired pneumonia [J]. Expert Rev Anti Infect Ther, 2010, 8 (5): 505 -514.
10Fu KP, Lafredo SC, Foleno B, et al. In vitro and in vivo antibacterial activities of levofloxacin (I - ofloxacin ), an optically active ofloxacin [J]. Antimicrob Agents Chemother, 1992, 36 (4): 860 -866.
